News

Study directly compares Zepbound and Wegovy for weight-loss results
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...
Health on MSN13d
Zepbound or Wegovy? Head-to-Head Trial Says One Is Better for Weight Loss
Eli Lilly’s Zepbound proved more effective than Novo Nordisk’s Wegovy in a new head-to-head trial, though both medications ...
Weight loss drugs, like Ozempic and Wegovy, are changing lives on Long Island — but at a crushing cost for some
Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...
Neurology Advisor1d
How GLP-1s Could Help People Sleep Better — Beyond Weight Loss
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
For diabetics, weight-loss drugs might lessen cancer risk, study finds
The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...
WHYY10d
Pa. and N.J. poison control centers see steep rise in exposure calls tied to popular weight-loss drugs
Poison control experts say calls related to GLP-1 weight-loss drugs like Wegovy and Zepbound are rising, with symptoms like ...
Food and fitness make or break success on weight loss meds, report finds
The report also underscored the importance of maintaining muscle mass and bone density while losing weight. Since weight loss ...
Barchart on MSN4d
Eli Lilly vs. Novo Nordisk: Which Stock Is the Winner of the Weight-Loss Drug Boom?
The global weight-loss drug market is experiencing exceptional growth, projected to expand from around $144.6 billion in 2023 ...